Nouvelles - Bioventus

octobre 8, 2019

National Institute for Health and Clinical Excellence Maintains Previous Recommendation for EXOGEN® Ultrasound Bone Healing System

HOOFDDORP, THE NETHERLANDS – October 8, 2019 – Bioventus, a global leader in orthobiologic solutions, has received notice from the United Kingdom’s…

septembre 9, 2019

Bioventus Agrees to Nationwide Contract with UnitedHealthcare® Commercial Plans, Members Have Access to DUROLANE® and GELSYN-3®for Knee Osteoarthritis

DURHAM, NC – September 9, 2019 – Bioventus, a global leader in orthobiologic solutions, has agreed to a nationwide contract with UnitedHealthcare…

août 13, 2019

Bioventus Launches DUROLANE® SJ (1mL) in Australia and New Zealand; Receives Expanded Indications for DUROLANE (3mL)

HOOFDDORP, THE NETHERLANDS – August 13, 2019 – Bioventus, a global leader in orthobiologic solutions, is launching DUROLANE SJ (1mL), and has…

juin 6, 2019

Bioventus to Co-Develop Next Generation Placental Tissue Product for Knee Osteoarthritis with MTF Biologics

DURHAM– June 6, 2019 – Bioventus, a global leader in orthobiologic solutions, has entered into a development collaboration agreement with MTF…

mars 27, 2019

Bioventus Launches OSTEOAMP SELECT Fibers

DURHAM, NC – March 27, 2019 – Bioventus, a global leader in orthobiologic solutions, is launching OSTEOAMP SELECT Fibers, an innovative addition to…

janvier 29, 2019

Bioventus Launches DUROLANE in Malaysia

HOOFDDORP, THE NETHERLANDS – January 29, 2019 – Bioventus, a global leader in orthobiologic solutions, is launching DUROLANE, its single-injection…

janvier 15, 2019

Bioventus Launches OSTEOMATRIX+® Biphasic Bone Graft

DURHAM, NC – January 15, 2019 – Bioventus, a global leader in orthobiologic solutions, is launching OSTEOMATRIX+, its next generation biphasic bone…

octobre 25, 2018

Susan M. Stalnecker Named to Bioventus Board of Managers

DURHAM, NC – October 25, 2018 – Bioventus, a global leader in orthobiologic solutions, today announced the appointment of Susan M. Stalnecker, former…

octobre 2, 2018

Bioventus Receives ANVISA Approval to Market DUROLANE in Brazil and Selects Pfizer as Exclusive Distribution Partner

HOOFDDORP, THE NETHERLANDS – October 2, 2018 – Bioventus, a global leader in orthobiologic solutions, has received approval from Agência Nacional de…

juillet 23, 2018

Bioventus Enters Into Definitive Agreement to Divest BMP Program

DURHAM, NC – July 23, 2018 – Bioventus, a global leader in orthobiologic solutions, has entered into a definitive agreement to divest its next…

Salle de presse

Recherche sur les nouvelles

Requêtes médiatiques

Bibliothèque de téléchargement